Factors associated with community acquired severe pneumonia among under five children in Dhaka, Bangladesh: A case control analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
02
2021
accepted:
08
03
2022
entrez:
23
3
2022
pubmed:
24
3
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Pneumonia is the leading cause of death in children globally with the majority of these deaths observed in resource-limited settings. Globally, the annual incidence of clinical pneumonia in under-five children is approximately 152 million, mostly in the low- and middle-income countries. Of these, 8.7% progressed to severe pneumonia requiring hospitalization. However, data to predict children at the greatest risk to develop severe pneumonia from pneumonia are limited. Secondary data analysis was performed after extracting relevant data from a prospective cluster randomized controlled clinical trial; children of either sex, aged two months to five years with pneumonia or severe pneumonia acquired in the community were enrolled over a period of three years in 16 clusters in urban Dhaka city. The analysis comprised of 2,597 children aged 2-59 months. Of these, 904 and 1693 were categorized as pneumonia (controls) and severe pneumonia (cases), respectively based on WHO criteria. The median age of children was 9.2 months (inter quartile range, 5.1-17.1) and 1,576 (60%) were male. After adjustment for covariates, children with temperature ≥38°C, duration of illness ≥3 days, male sex, received prior medical care and severe stunting showed a significantly increased likelihood of developing severe pneumonia compared to those with pneumonia. Severe pneumonia in children occurred more often in older children who presented commonly from wealthy quintile families, and who often sought care from private facilities in urban settings. Male sex, longer duration of illness, fever, received prior medical care, and severe stunting were significantly associated with development of WHO-defined severe childhood pneumonia in our population. The results of this study may help to develop interventions target to reduce childhood morbidity and mortality of children suffering from severe pneumonia.
Sections du résumé
BACKGROUND
Pneumonia is the leading cause of death in children globally with the majority of these deaths observed in resource-limited settings. Globally, the annual incidence of clinical pneumonia in under-five children is approximately 152 million, mostly in the low- and middle-income countries. Of these, 8.7% progressed to severe pneumonia requiring hospitalization. However, data to predict children at the greatest risk to develop severe pneumonia from pneumonia are limited.
METHOD
Secondary data analysis was performed after extracting relevant data from a prospective cluster randomized controlled clinical trial; children of either sex, aged two months to five years with pneumonia or severe pneumonia acquired in the community were enrolled over a period of three years in 16 clusters in urban Dhaka city.
RESULTS
The analysis comprised of 2,597 children aged 2-59 months. Of these, 904 and 1693 were categorized as pneumonia (controls) and severe pneumonia (cases), respectively based on WHO criteria. The median age of children was 9.2 months (inter quartile range, 5.1-17.1) and 1,576 (60%) were male. After adjustment for covariates, children with temperature ≥38°C, duration of illness ≥3 days, male sex, received prior medical care and severe stunting showed a significantly increased likelihood of developing severe pneumonia compared to those with pneumonia. Severe pneumonia in children occurred more often in older children who presented commonly from wealthy quintile families, and who often sought care from private facilities in urban settings.
CONCLUSION AND RECOMMENDATION
Male sex, longer duration of illness, fever, received prior medical care, and severe stunting were significantly associated with development of WHO-defined severe childhood pneumonia in our population. The results of this study may help to develop interventions target to reduce childhood morbidity and mortality of children suffering from severe pneumonia.
Identifiants
pubmed: 35320317
doi: 10.1371/journal.pone.0265871
pii: PONE-D-21-06226
pmc: PMC8942236
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265871Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Bull World Health Organ. 1997;75 Suppl 1:119-28
pubmed: 9529725
PLoS One. 2012;7(6):e39164
pubmed: 22720060
PLoS One. 2019 Jan 10;14(1):e0210433
pubmed: 30629689
Am J Epidemiol. 2003 Aug 15;158(4):374-84
pubmed: 12915503
Int J Epidemiol. 2004 Dec;33(6):1362-72
pubmed: 15166188
Thorax. 2011 Oct;66 Suppl 2:ii1-23
pubmed: 21903691
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
PLoS One. 2015 May 12;10(5):e0125865
pubmed: 25965382
Int J Tuberc Lung Dis. 2001 Jun;5(6):511-9
pubmed: 11409576
BMC Public Health. 2016 Dec 7;16(1):1233
pubmed: 27927201
J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):323-334
pubmed: 29850828
Eur J Pediatr. 2013 Apr;172(4):493-9
pubmed: 23271491
MMWR Morb Mortal Wkly Rep. 2005 Sep 16;54(36):893-7
pubmed: 16163262
Pediatrics. 2016 Oct;138(4):
pubmed: 27688362
PLoS One. 2012;7(1):e27793
pubmed: 22238570
Lancet. 2013 Apr 20;381(9875):1405-1416
pubmed: 23582727
Trop Med Int Health. 2015 Oct;20(10):1320-8
pubmed: 26083963
PLoS One. 2019 Mar 7;14(3):e0213238
pubmed: 30845206
Lancet. 2008 Jan 5;371(9606):49-56
pubmed: 18177775
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
J Health Popul Nutr. 2007 Jun;25(2):179-88
pubmed: 17985819
Respirology. 2017 Oct;22(7):1276-1287
pubmed: 28681972
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
BMC Pediatr. 2019 Oct 27;19(1):386
pubmed: 31656181
Trop Med Int Health. 2019 Apr;24(4):484-492
pubmed: 30702791
Pan Afr Med J. 2012;13:45
pubmed: 23330036
Lancet. 1997 Jun 7;349(9066):1693-5
pubmed: 9186397
Bull World Health Organ. 2004 Dec;82(12):895-903
pubmed: 15654403
J Trop Pediatr. 2003 Dec;49(6):327-32
pubmed: 14725409
Bull World Health Organ. 2008 May;86(5):349-55
pubmed: 18545737
Bull World Health Organ. 2008 May;86(5):408-16
pubmed: 18545744
J Health Popul Nutr. 2007 Mar;25(1):47-61
pubmed: 17615903
Trop Med Int Health. 2009 Oct;14(10):1173-89
pubmed: 19772545
Lancet Infect Dis. 2009 Apr;9(4):219-27
pubmed: 19324294
Infect Dis Poverty. 2014 Apr 24;3:14
pubmed: 24834348
Lancet Glob Health. 2016 Jan;4(1):e12-3
pubmed: 26577842